Drug patent dispute to get fiercer

Patent dispute for pharmaceuticals will get fiercer as many Korean drug makers are rushing to introduce first generic versions of original brands whose patents are to be expired, with hope of acquiring large share of the patented drug’s market.

According to the Korean Intellectual Property Office, the number of patient infringement (nullification) suits as well as trials to confirm the scop...